טוען...
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
The treatment of metastatic colorectal cancer (mCRC) harboring BRAF V600 mutations is challenging. These tumors are often refractory to standard treatment. Therefore, the patients may exhibit rapid clinical deterioration, depriving them of the chance to receive salvage therapy. In newly diagnosed pa...
שמור ב:
| הוצא לאור ב: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7579731/ https://ncbi.nlm.nih.gov/pubmed/33133378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v12.i10.1080 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|